Privia Health Group, Inc. (NASDAQ:PRVA) Receives Consensus Recommendation of “Buy” from Analysts

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have been assigned a consensus recommendation of “Buy” from the sixteen research firms that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold recommendation, thirteen have assigned a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year target price among brokerages that have issued ratings on the stock in the last year is $26.47.

A number of research analysts have recently commented on the company. Stephens reissued an “overweight” rating and set a $26.00 price objective on shares of Privia Health Group in a report on Thursday, January 2nd. Needham & Company LLC increased their price objective on Privia Health Group from $25.00 to $30.00 and gave the company a “buy” rating in a report on Friday. Piper Sandler increased their price objective on Privia Health Group from $25.00 to $40.00 and gave the company an “overweight” rating in a report on Friday. JMP Securities restated a “market outperform” rating and set a $26.00 target price on shares of Privia Health Group in a research note on Friday, February 14th. Finally, Macquarie began coverage on Privia Health Group in a research note on Monday, December 16th. They set an “outperform” rating and a $25.00 target price for the company.

Institutional Trading of Privia Health Group

Hedge funds have recently modified their holdings of the company. First Horizon Advisors Inc. lifted its position in shares of Privia Health Group by 53.8% in the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock worth $35,000 after acquiring an additional 632 shares during the period. EverSource Wealth Advisors LLC lifted its position in shares of Privia Health Group by 7,833.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock worth $47,000 after acquiring an additional 2,350 shares during the period. Financial Management Professionals Inc. bought a new stake in shares of Privia Health Group in the 4th quarter worth approximately $51,000. Quarry LP boosted its stake in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock valued at $60,000 after buying an additional 2,533 shares in the last quarter. Finally, KBC Group NV boosted its stake in Privia Health Group by 34.6% in the 3rd quarter. KBC Group NV now owns 3,385 shares of the company’s stock valued at $62,000 after buying an additional 871 shares in the last quarter. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Stock Performance

Shares of NASDAQ PRVA opened at $24.96 on Thursday. The firm has a market cap of $3.00 billion, a price-to-earnings ratio of 249.62, a P/E/G ratio of 3.47 and a beta of 0.87. The business’s 50-day simple moving average is $22.50 and its 200-day simple moving average is $20.64. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $26.04.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.